The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thomas, L. L.
Right arrow Articles by Ardon, T. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thomas, L. L.
Right arrow Articles by Ardon, T. T.
The Journal of Immunology, 2002, 169: 993-999.
Copyright © 2002 by The American Association of Immunologists

Immobilized Lactoferrin Is a Stimulus for Eosinophil Activation1

Larry L. Thomas2,*, Wei Xu* and Tamir T. Ardon{dagger}

* Department of Immunology/Microbiology, Rush Medical College, Chicago, IL 60612; and {dagger} Beloit College, Beloit, WI 53511

Eosinophils are strongly implicated in the pathogenesis of asthma, particularly in damage to the airway epithelial lining. We examined the potential for lactoferrin, a multifunctional glycoprotein present in the airway surface liquid, to activate eosinophils. Incubating eosinophils in tissue culture wells pretreated with 1–100 µg/ml human lactoferrin stimulated concentration-dependent superoxide production by eosinophils. The same concentrations of immobilized transferrin were without effect. The potency of immobilized lactoferrin was approximately one-third that of immobilized secretory IgA in the same experiments. In contrast, immobilized lactoferrin did not stimulate neutrophil superoxide production. Eosinophils bound lactoferrin as determined by flow cytometry and by binding of 125I-labeled lactoferrin. Transferrin did not block binding of 125I-labeled lactoferrin. Soluble lactoferrin, however, did not activate the eosinophils and did not block superoxide production stimulated by immobilized lactoferrin. Immobilized lactoferrin also stimulated release of eosinophil-derived neurotoxin and low levels of leukotriene C4 production; the latter was significantly enhanced in the presence of 100 pg/ml GM-CSF. GM-CSF also enhanced superoxide production and eosinophil-derived neurotoxin release stimulated by the lower concentrations of immobilized lactoferrin. Pretreatment of the lactoferrin with peptide N-glycosidase F or addition of heparin or chondroitin sulfate to the incubation contents had no or only a minimal effect on the activity of immobilized lactoferrin. These results demonstrate that lactoferrin adherent to the surface epithelium may contribute to the activation of eosinophils that infiltrate the airway lumen in eosinophil-associated disorders such as asthma.




This article has been cited by other articles:


Home page
FASEB J.Home page
M. Spadaro, C. Caorsi, P. Ceruti, A. Varadhachary, G. Forni, F. Pericle, and M. Giovarelli
Lactoferrin, a major defense protein of innate immunity, is a novel maturation factor for human dendritic cells
FASEB J, August 1, 2008; 22(8): 2747 - 2757.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. P. Ward, M. Mendoza-Meneses, P. W. Park, and O. M. Conneely
Stimulus-Dependent Impairment of the Neutrophil Oxidative Burst Response in Lactoferrin-Deficient Mice
Am. J. Pathol., April 1, 2008; 172(4): 1019 - 1029.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Monteseirin, A. Vega, P. Chacon, M. J. Camacho, R. El Bekay, J. A. Asturias, A. Martinez, P. Guardia, R. Perez-Cano, and J. Conde
Neutrophils as a Novel Source of Eosinophil Cationic Protein in IgE-Mediated Processes
J. Immunol., August 15, 2007; 179(4): 2634 - 2641.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. G. Shenoy, G. J. Gleich, and L. L. Thomas
Eosinophil Major Basic Protein Stimulates Neutrophil Superoxide Production by a Class IA Phosphoinositide 3-Kinase and Protein Kinase C-{zeta}-Dependent Pathway
J. Immunol., October 1, 2003; 171(7): 3734 - 3741.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.